Summary of linear regression model of log-transformed tumor volumes. حسب Chi-Feng Chiang (16534951)

الموضوعات:

Descriptive characteristics of service utilization by sex and year. حسب Fernanda Talarico (807333)

الموضوعات:

Comparison of mental health-related service utilization between the pre (2016–2019) and post (2020–2022) pandemic onset periods. حسب Fernanda Talarico (807333)

الموضوعات:

Cohort characteristics. حسب Fernanda Talarico (807333)

الموضوعات:

Trend of specific mental health disorders for all services utilization between 2016 and 2022. حسب Fernanda Talarico (807333)

الموضوعات:

Trend of mental health-related services utilization between 2016 and 2022. حسب Fernanda Talarico (807333)

الموضوعات:

Comparison of mental health-related services utilization between the pre (2016–2019) and post (2020–2022) pandemic onset periods. حسب Fernanda Talarico (807333)

الموضوعات:

Trend of all service utilization for all conditions between 2016 and 2022. حسب Fernanda Talarico (807333)

الموضوعات:

Occurrence of species that increased and decreased across surveys. حسب Paul H. Zedler (2905520)

Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

الموضوعات:

Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the incidence of <i>Clostridioides difficile</i> infection (CDI) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phas... حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the incidence of extended-spectrum β-lactamase (ESBL)- producing Enterobacteriaceae per 1000 patients, by month, during the pre-intervention period (Phase 1) and interven... حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the incidence of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional pe... حسب Naoya Itoh (6029276)

الموضوعات: